ATE141946T1 - Hiv-2-virusvarianten - Google Patents
Hiv-2-virusvariantenInfo
- Publication number
- ATE141946T1 ATE141946T1 AT89710057T AT89710057T ATE141946T1 AT E141946 T1 ATE141946 T1 AT E141946T1 AT 89710057 T AT89710057 T AT 89710057T AT 89710057 T AT89710057 T AT 89710057T AT E141946 T1 ATE141946 T1 AT E141946T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- virus
- virus variants
- rna
- dna
- Prior art date
Links
- 241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3820223 | 1988-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE141946T1 true ATE141946T1 (de) | 1996-09-15 |
Family
ID=6356522
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95100149T ATE241014T2 (de) | 1988-06-14 | 1989-06-13 | Hiv-2 varianten |
AT89710057T ATE141946T1 (de) | 1988-06-14 | 1989-06-13 | Hiv-2-virusvarianten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95100149T ATE241014T2 (de) | 1988-06-14 | 1989-06-13 | Hiv-2 varianten |
Country Status (9)
Country | Link |
---|---|
US (2) | US5637455A (de) |
EP (2) | EP0347365B1 (de) |
JP (1) | JP3088005B2 (de) |
KR (1) | KR960010948B1 (de) |
AT (2) | ATE241014T2 (de) |
AU (1) | AU625174B2 (de) |
CA (1) | CA1340747C (de) |
DE (2) | DE68929467T3 (de) |
ES (1) | ES2194029T5 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5278042A (en) * | 1989-02-06 | 1994-01-11 | The United States Of America As Represented By The Department Of Health & Human Services | Method for detecting inhibitors of tat protein |
DE3934366A1 (de) * | 1989-10-14 | 1991-04-18 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum |
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US6428955B1 (en) | 1995-03-17 | 2002-08-06 | Sequenom, Inc. | DNA diagnostics based on mass spectrometry |
US5962665A (en) * | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
US6846905B2 (en) * | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
US6207370B1 (en) | 1997-09-02 | 2001-03-27 | Sequenom, Inc. | Diagnostics based on mass spectrometric detection of translated target polypeptides |
US6492110B1 (en) | 1998-11-02 | 2002-12-10 | Uab Research Foundation | Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1 |
US6723564B2 (en) | 1998-05-07 | 2004-04-20 | Sequenom, Inc. | IR MALDI mass spectrometry of nucleic acids using liquid matrices |
US7244570B2 (en) | 1998-08-04 | 2007-07-17 | Luminex Molecular Diagnostics, Inc. | Methods and compositions for modulating “marginally indiscriminant” hybridizations |
WO2002034951A2 (en) | 2000-10-23 | 2002-05-02 | Gen-Probe Incorporated | Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
US9394565B2 (en) | 2003-09-05 | 2016-07-19 | Agena Bioscience, Inc. | Allele-specific sequence variation analysis |
AU2005230936B2 (en) | 2004-03-26 | 2010-08-05 | Agena Bioscience, Inc. | Base specific cleavage of methylation-specific amplification products in combination with mass analysis |
CA2603730A1 (en) | 2005-03-31 | 2006-10-05 | Calando Pharmaceuticals, Inc. | Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
EP3699291A1 (de) | 2008-01-17 | 2020-08-26 | Sequenom, Inc. | Einzelmolekülnukleinsäurensequenzanalyseverfahren und zusammensetzungen |
EP2550362B1 (de) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv-glycoproteine und rekombinante vektoren |
EP2710144B1 (de) | 2011-05-19 | 2020-10-07 | Agena Bioscience, Inc. | Verfahren zur multiplex-identifizierung von nukleinsäuren |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
EP3286327B1 (de) | 2015-04-24 | 2021-11-10 | Agena Bioscience, Inc. | Gemultiplexte verfahren zur identifizierung und quantifizierung von minder vorhandenen allelen und polymorphismen |
EP3286328B1 (de) | 2015-04-24 | 2020-10-21 | Agena Bioscience, Inc. | Multiplex verfahrens für detektion und quantifizierung leichten varianten |
US9925258B2 (en) | 2015-10-02 | 2018-03-27 | International Aids Vaccine Initiative | Replication-competent VSV-HIV Env vaccines |
KR101933494B1 (ko) * | 2018-04-17 | 2018-12-31 | 이재욱 | 내연기관의 출력 증강을 위한 소음 저감형 배기 장치 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE239425T1 (de) † | 1986-01-22 | 1988-06-30 | Institut Pasteur, Paris | Zum hervorrufen von aids geeigneter retrovirus vom typ hiv-2, sowie seine antigen- und nukleinsaeure-bestandteile. |
EP0269520A3 (de) * | 1986-11-21 | 1988-08-24 | Institut Pasteur | Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile |
US4956292A (en) * | 1987-10-29 | 1990-09-11 | Institut Pasteur | Viral strain isolated from cerebrospinal fluid of an HIV seropositive man having acute and regressive encephalopathy and use of the strain in an immunoassay |
WO1989006276A2 (en) * | 1988-01-08 | 1989-07-13 | Dpz Deutsches Primatenzentrum Gesellschaft Mbh | Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
WO1989009815A1 (en) * | 1988-04-04 | 1989-10-19 | Research Corporation Technologies, Inc. | Novel virus of the hiv-2 family and methods of detection therefor |
-
1989
- 1989-06-13 AT AT95100149T patent/ATE241014T2/de not_active IP Right Cessation
- 1989-06-13 AT AT89710057T patent/ATE141946T1/de not_active IP Right Cessation
- 1989-06-13 DE DE68929467.0T patent/DE68929467T3/de not_active Expired - Lifetime
- 1989-06-13 EP EP89710057A patent/EP0347365B1/de not_active Expired - Lifetime
- 1989-06-13 CA CA000602608A patent/CA1340747C/en not_active Expired - Lifetime
- 1989-06-13 ES ES95100149.4T patent/ES2194029T5/es not_active Expired - Lifetime
- 1989-06-13 EP EP95100149.4A patent/EP0655501B2/de not_active Expired - Lifetime
- 1989-06-13 DE DE68927025T patent/DE68927025T2/de not_active Expired - Lifetime
- 1989-06-14 JP JP01153570A patent/JP3088005B2/ja not_active Expired - Lifetime
- 1989-06-14 KR KR1019890008221A patent/KR960010948B1/ko not_active IP Right Cessation
- 1989-06-14 AU AU36361/89A patent/AU625174B2/en not_active Expired
-
1994
- 1994-12-14 US US08/358,575 patent/US5637455A/en not_active Expired - Lifetime
-
1996
- 1996-07-22 US US08/684,682 patent/US5677147A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0655501A1 (de) | 1995-05-31 |
EP0655501B1 (de) | 2003-05-21 |
ES2194029T5 (es) | 2016-10-26 |
CA1340747C (en) | 1999-09-14 |
AU625174B2 (en) | 1992-07-02 |
US5677147A (en) | 1997-10-14 |
US5637455A (en) | 1997-06-10 |
KR900000476A (ko) | 1990-01-30 |
JPH02131576A (ja) | 1990-05-21 |
DE68929467D1 (de) | 2003-06-26 |
ES2194029T3 (es) | 2003-11-16 |
DE68927025D1 (de) | 1996-10-02 |
DE68929467T3 (de) | 2016-12-22 |
EP0347365A3 (de) | 1991-10-02 |
EP0655501B2 (de) | 2016-07-27 |
EP0347365A2 (de) | 1989-12-20 |
JP3088005B2 (ja) | 2000-09-18 |
ATE241014T2 (de) | 2003-06-15 |
DE68929467T2 (de) | 2004-04-15 |
EP0347365B1 (de) | 1996-08-28 |
KR960010948B1 (ko) | 1996-08-14 |
DE68927025T2 (de) | 1997-03-27 |
AU3636189A (en) | 1990-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929467D1 (de) | HIV-2 Varianten | |
GR3034708T3 (en) | Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof. | |
DE10299049I1 (de) | Rekombinante Viren. | |
FI864016A0 (fi) | Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1. | |
CA2011878A1 (en) | Immunogenic regions on the e7 protein of human papillomavirus type 16 | |
NO871025L (no) | Polypeptid, dna og fremgangsmaate for fremstilling derav. | |
NO912825L (no) | Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper. | |
DK0817851T3 (da) | DNA, der koder for humant papillomvirus type 18 | |
DK476688D0 (da) | Hiv-proteiner og -peptider, der er nyttige ved aids-diagnose, -profylakse og -terapi | |
ATE103980T1 (de) | Das f-protein vom aids-virus enthaltender impfstoff. | |
DK498387D0 (da) | Virus-dna-sekvens | |
DE58909339D1 (de) | Humaner Papillomvirus Typ 57, seine DNA und die davon kodierten Proteine. | |
DK161487D0 (da) | Alfa-interferon-analoge og fremgangsmaade til fremstilling deraf samt udtrykkelsesvektorer og vaertsorganismer til anvendelse ved fremgangsmaaden. | |
DE3850323D1 (de) | Virusvektor und Rekombinante DNS, die ein oder mehrere strukturelle Proteine (HA,F und/oder NP) eines Morbillivirus Kodieren. | |
NO891691D0 (no) | Rekombinant gag-forloeper for hiv. | |
FI893346A0 (fi) | Icke-reverterande rna-virus. | |
DE3788424D1 (de) | Testverfahren des menschlichen b-lymphotropen virus (hblv). | |
IT8919930A0 (it) | Procedimento per marcare cromosomi utilizzando dna ripetitivo ricombinante. | |
ATE98379T1 (de) | Testverfahren des menschlichen b-lymphotropen virus (hblv). | |
ATE102252T1 (de) | Rekombinantes gefluegelpockenvirus, expressionsvektoren fuer heterologische proteine und davon derivierte gefluegelvakzine. | |
MX9203296A (es) | Proteinas bmp-7. | |
AUPN003194A0 (en) | Vaccine for the hiv-1 & hiv-2 virus | |
NO891355D0 (no) | Vaksinasjon mot rabis-beslektede virus. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |